These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33494623)

  • 21. Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport.
    Wilson V; Lou X; Osterling DJ; Stolarik DF; Jenkins G; Gao W; Zhang GGZ; Taylor LS
    J Control Release; 2018 Dec; 292():172-182. PubMed ID: 30408553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT; Lee PI
    J Pharm Sci; 2021 Apr; 110(4):1495-1512. PubMed ID: 32818440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
    Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
    Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tangential flow absorption model (TFAM) - A novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives.
    Haering B; Seyferth S; Schiffter HA
    Eur J Pharm Biopharm; 2020 Sep; 154():74-88. PubMed ID: 32585350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supersaturation and crystallization: non-equilibrium dynamics of amorphous solid dispersions for oral drug delivery.
    Kawakami K
    Expert Opin Drug Deliv; 2017 Jun; 14(6):735-743. PubMed ID: 27598556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theoretical evaluation of supersaturation of amorphous solid dispersion formulations with different drug/polymer combinations using mathematical modeling.
    Hirai D; Tsunematsu H; Kimura SI; Itai S; Fukami T; Iwao Y
    Int J Pharm; 2022 Sep; 625():122110. PubMed ID: 35970282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions.
    Suzuki K; Kawakami K; Fukiage M; Oikawa M; Nishida Y; Matsuda M; Fujita T
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD; Lee PI
    Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
    Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
    Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS
    AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biorelevant dissolution testing and physiologically based absorption modeling to predict in vivo performance of supersaturating drug delivery systems.
    Thakore SD; Sirvi A; Joshi VC; Panigrahi SS; Manna A; Singh R; Sangamwar AT; Bansal AK
    Int J Pharm; 2021 Sep; 607():120958. PubMed ID: 34332060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of surfactants on the dissolution behavior of amorphous formulations.
    Mah PT; Peltonen L; Novakovic D; Rades T; Strachan CJ; Laaksonen T
    Eur J Pharm Biopharm; 2016 Jun; 103():13-22. PubMed ID: 26955750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.